SWP
TXG icon

Stratos Wealth Partners’s 10x Genomics TXG Stock Holding History

Stratos Wealth Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$531K Sell
13,852
-200
-1% -$5.24K 0.01% 1114
2026
Q1 		$298K Hold
14,052
– – ﹤0.01% 1325
2025
Q4 		$229K Buy
14,052
+950
+7% +$14.4K ﹤0.01% 1440
2025
Q3 		$153K Buy
+13,102
New +$171K ﹤0.01% 1497

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stratos Wealth Partners's TXG Position: Q2 2026 in Review

Stratos Wealth Partners reduced its 10x Genomics (TXG) stake by 1.4% in Q2 2026, selling an estimated $5.24K and leaving 13,852 shares worth $531K. The position accounts for 0.01% of the portfolio, ranked #1114.

Stratos Wealth Partners first reported a position in TXG in Q3 2025 and has held it in 4 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Stratos Wealth Partners held 13,852 shares of 10x Genomics worth $531K as of Q2 2026.
  • Stratos Wealth Partners sold 200 10x Genomics shares in Q2 2026, an estimated $5.24K.
  • 10x Genomics made up 0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #1114 holding.
  • Stratos Wealth Partners first reported a position in 10x Genomics in Q3 2025 and has held it in 4 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.